Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/11/23
End: 04/10/24
Due: 04/10/25
Phase: N/A
Priority: Normal
Start: 08/04/23
End: 07/25/24
Due: 07/25/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States | NCT05870839 | Vaccine Company, Inc. | user2@example.com | None | 2023-05-11 | 2024-04-10 | 2025-04-10 | - | - | 2025-07-14 |
| Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa | NCT05938075 | Vaccine Company, Inc. | user2@example.com | None | 2023-08-04 | 2024-07-25 | 2025-07-25 | - | - | 2025-07-14 |